JP2012509919A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012509919A5 JP2012509919A5 JP2011537896A JP2011537896A JP2012509919A5 JP 2012509919 A5 JP2012509919 A5 JP 2012509919A5 JP 2011537896 A JP2011537896 A JP 2011537896A JP 2011537896 A JP2011537896 A JP 2011537896A JP 2012509919 A5 JP2012509919 A5 JP 2012509919A5
- Authority
- JP
- Japan
- Prior art keywords
- calcium sulfate
- cmc
- calculated
- composition
- sodium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims 22
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims 14
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims 12
- 239000001768 carboxy methyl cellulose Substances 0.000 claims 12
- 239000000203 mixture Substances 0.000 claims 10
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims 10
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims 10
- 235000011132 calcium sulphate Nutrition 0.000 claims 9
- 239000013543 active substance Substances 0.000 claims 6
- ZOMBKNNSYQHRCA-UHFFFAOYSA-J calcium sulfate hemihydrate Chemical compound O.[Ca+2].[Ca+2].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O ZOMBKNNSYQHRCA-UHFFFAOYSA-J 0.000 claims 4
- 201000010099 disease Diseases 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 238000000034 method Methods 0.000 claims 3
- 239000002245 particle Substances 0.000 claims 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 2
- 230000002280 anti-androgenic effect Effects 0.000 claims 2
- 239000000051 antiandrogen Substances 0.000 claims 2
- 239000001175 calcium sulphate Substances 0.000 claims 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims 2
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 claims 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims 2
- 229940105329 carboxymethylcellulose Drugs 0.000 claims 2
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 claims 2
- 229960002074 flutamide Drugs 0.000 claims 2
- MKXKFYHWDHIYRV-UHFFFAOYSA-N flutamide Chemical compound CC(C)C(=O)NC1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1 MKXKFYHWDHIYRV-UHFFFAOYSA-N 0.000 claims 2
- 239000011734 sodium Substances 0.000 claims 2
- 229910052708 sodium Inorganic materials 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- LKJPYSCBVHEWIU-KRWDZBQOSA-N (R)-bicalutamide Chemical compound C([C@@](O)(C)C(=O)NC=1C=C(C(C#N)=CC=1)C(F)(F)F)S(=O)(=O)C1=CC=C(F)C=C1 LKJPYSCBVHEWIU-KRWDZBQOSA-N 0.000 claims 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 claims 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 1
- 239000012736 aqueous medium Substances 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 229960000997 bicalutamide Drugs 0.000 claims 1
- 239000011575 calcium Substances 0.000 claims 1
- 229910052791 calcium Inorganic materials 0.000 claims 1
- 229920002678 cellulose Polymers 0.000 claims 1
- 239000001913 cellulose Substances 0.000 claims 1
- DUSHUSLJJMDGTE-ZJPMUUANSA-N cyproterone Chemical compound C1=C(Cl)C2=CC(=O)[C@@H]3C[C@@H]3[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)C)(O)[C@@]1(C)CC2 DUSHUSLJJMDGTE-ZJPMUUANSA-N 0.000 claims 1
- 229960003843 cyproterone Drugs 0.000 claims 1
- 150000004683 dihydrates Chemical class 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- YPQLFJODEKMJEF-UHFFFAOYSA-N hydroxyflutamide Chemical compound CC(C)(O)C(=O)NC1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1 YPQLFJODEKMJEF-UHFFFAOYSA-N 0.000 claims 1
- 210000002307 prostate Anatomy 0.000 claims 1
- 201000007094 prostatitis Diseases 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200801674 | 2008-11-27 | ||
| DKPA200801674 | 2008-11-27 | ||
| PCT/EP2009/008496 WO2010060644A1 (en) | 2008-11-27 | 2009-11-27 | Use of carboxymethylcellulose to control ejectability and solidification of time of compositions one or more bioresorbable ceramics |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012509919A JP2012509919A (ja) | 2012-04-26 |
| JP2012509919A5 true JP2012509919A5 (cg-RX-API-DMAC10.html) | 2013-01-24 |
| JP5702294B2 JP5702294B2 (ja) | 2015-04-15 |
Family
ID=40823443
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011537896A Active JP5702294B2 (ja) | 2008-11-27 | 2009-11-27 | 一以上の生物吸収性セラミックを含む組成物の吐出性および凝固時間を制御するための、カルボキシメチルセルロースの使用 |
Country Status (14)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105727370B (zh) * | 2016-02-18 | 2018-11-06 | 江苏西宏生物医药有限公司 | 一种注射植入剂 |
| US11752099B2 (en) | 2017-03-27 | 2023-09-12 | W. L. Gore & Associates, Inc. | Injectable and biodegradable polymer formulations for controlled release of bioactive agents |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB999487A (en) * | 1963-05-03 | 1965-07-28 | Ici Ltd | Set-retarded calcium sulphate hemihydrate |
| US3891453A (en) * | 1973-07-26 | 1975-06-24 | United States Gypsum Co | Asbestos-free joint compounds |
| GB1506897A (en) * | 1975-11-05 | 1978-04-12 | Ici Ltd | Method of securing fixing elements in rock |
| JPS5626756A (en) * | 1979-08-10 | 1981-03-14 | Sato Hironobu | Manufacture of alpha gypsum |
| HU197207B (en) * | 1985-12-04 | 1989-03-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing pharmaceutical comprising 1-(3',4'-diethoxybenzyl)-6,7-diethoxy-3,4-dihydro-isoquinolinium-theophylline-7-acetate or its monohydrate as active ingredient |
| CA2268156C (en) | 1996-10-16 | 2007-05-29 | Etex Corporation | Bioceramic compositions |
| JP2000264710A (ja) * | 1999-03-23 | 2000-09-26 | Mitsui Chemicals Inc | 型材用流し込み組成物 |
| CA2378486A1 (en) | 1999-08-05 | 2001-02-15 | Takashi Kurasawa | Osteogenesis promoter sustained-release paste |
| US7371409B2 (en) * | 2001-09-06 | 2008-05-13 | Wright Medical Technology, Inc. | Bone graft substitute composition |
| US7291179B2 (en) * | 2002-06-24 | 2007-11-06 | Wright Medical Technology, Inc. | Bone graft substitute composition |
| US6652887B1 (en) * | 2002-06-24 | 2003-11-25 | Wright Medical Technology, Inc. | Bone graft substitute composition |
| AU2002335562B2 (en) * | 2002-09-30 | 2007-07-05 | Regen Biotech, Inc. | Bone-filling composition for stimulating bone-forming and bone-consolidation comprising calcium sulfate and viscous biopolymers |
| WO2004108625A1 (en) * | 2003-06-05 | 2004-12-16 | Borden Chemical, Inc. | Gypsum products and method for their manufacture |
| PL1680089T3 (pl) * | 2003-10-22 | 2014-03-31 | Lidds Ab | Kompozycja zawierająca biodegradowalną ceramikę hydratującą do kontrolowanego dostarczania leków |
| US7671012B2 (en) * | 2004-02-10 | 2010-03-02 | Biosurface Engineering Technologies, Inc. | Formulations and methods for delivery of growth factor analogs |
| KR20140014294A (ko) * | 2005-03-31 | 2014-02-05 | 리드스 에이비 | 유효 물질의 국소 전달을 기본으로 하는 전립선 질병의 치료 방법 |
| AU2007224651B8 (en) * | 2006-03-14 | 2011-10-27 | Lidds Ab | Bioresorbable controlled-release composition |
| DE102008022086A1 (de) * | 2008-05-05 | 2009-11-12 | Schulz, Hans H. | Zweikomponenten-Alginat |
-
2009
- 2009-11-27 MX MX2011005243A patent/MX2011005243A/es active IP Right Grant
- 2009-11-27 RU RU2011126176/15A patent/RU2536415C2/ru active
- 2009-11-27 AU AU2009319348A patent/AU2009319348B2/en not_active Ceased
- 2009-11-27 WO PCT/EP2009/008496 patent/WO2010060644A1/en not_active Ceased
- 2009-11-27 DK DK09764455.3T patent/DK2376135T3/en active
- 2009-11-27 US US13/127,331 patent/US9198884B2/en active Active
- 2009-11-27 EP EP09764455.3A patent/EP2376135B1/en active Active
- 2009-11-27 JP JP2011537896A patent/JP5702294B2/ja active Active
- 2009-11-27 ES ES09764455.3T patent/ES2545962T3/es active Active
- 2009-11-27 CN CN2009801477087A patent/CN102227228A/zh active Pending
- 2009-11-27 CA CA2744141A patent/CA2744141C/en active Active
- 2009-11-27 KR KR1020117014428A patent/KR101632430B1/ko not_active Expired - Fee Related
-
2011
- 2011-05-02 IL IL212624A patent/IL212624A/en active IP Right Grant
- 2011-05-24 ZA ZA2011/03805A patent/ZA201103805B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101828550B (zh) | 复合过一硫酸氢钾消毒片的组成及其制备工艺 | |
| CN102350298A (zh) | 一种净水用的多功能复合吸附材料及其制备方法 | |
| JP2011500711A5 (cg-RX-API-DMAC10.html) | ||
| WO2011161056A3 (en) | Dialysis precursor composition | |
| WO2007122580A3 (en) | Compositions of phenylephrine useful for treatment of respiratory illness | |
| BR112014005286A2 (pt) | composições, métodos, e sistemas para a síntese e uso de agentes de imageamento | |
| PE20080331A1 (es) | Composiciones farmaceuticas estabilizadas que comprenden fesoterodina | |
| WO2011056985A3 (en) | Substituted heterocyclic compounds | |
| RU2013151904A (ru) | Применение соединений мышьяка для лечения отторжения ткани или органа | |
| JP2008534546A5 (cg-RX-API-DMAC10.html) | ||
| CL2013001459A1 (es) | Compuestos derivados de quinazolincarboxamida azetidina; proceso para prepararlos; composicion farmaceutica que los comprende; set (kit); y su uso para el tratamiento de enfermedades hiperproliferativas tales como cancer, inflamacion, pancreatitis o enfermedad renal, dolor, hiperplasia benigna de piel entre otras. | |
| TW201129386A (en) | Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients | |
| JP2021500092A5 (cg-RX-API-DMAC10.html) | ||
| CN106317999B (zh) | 一种释放负氧离子的脱硫石膏腻子 | |
| JP2013544892A5 (cg-RX-API-DMAC10.html) | ||
| CN101658170B (zh) | 一种用于混凝土所使用的聚羧酸减水剂的防腐剂 | |
| JP2010514556A5 (cg-RX-API-DMAC10.html) | ||
| JP2009514786A5 (cg-RX-API-DMAC10.html) | ||
| BR112012005667A2 (pt) | '' agente fluorescente particulado topoespec´fico, composição detergente, composição cosmética, processos de preparação de um agente fluorescente particulado bipolar, uso de uma particula de argila de uso de um agente fluorescente particulado'' | |
| RU2013152229A (ru) | Составы 2-иминобиотина и их применение | |
| JP2009149532A5 (cg-RX-API-DMAC10.html) | ||
| WO2011063775A3 (en) | Pectin complexes of sartans and pharmaceutical compositions based thereon | |
| WO2008040987A3 (en) | Biocidal formulation | |
| JP2006182655A5 (cg-RX-API-DMAC10.html) | ||
| RU2011126176A (ru) | Применение карбоксиметилцеллюлозы для контроля выдавливаемости и времени затвердения композиций, содержащих один или более керамических материалов |